UC Davis Comprehensive Cancer Center
2279 45th Street
Sacramento, CA 95817
Additional Phone Numbers
Philosophy of Care
It is truly a great privilege to provide care for children with acute needs in the fields of hematology and oncology. This area of medicine has advanced through cooperation and sharing of information and novel therapeutics. I believe in open and direct communication with families on a regular basis to empower families so that as a team we can help to provide the best possible care for their child.
Dr. Panigrahi is a pediatric hematology/oncology specialist offering care for children with various cancer diagnoses such as leukemia, lymphoma and neuroblastoma. He also focuses his practice on various hematological conditions such as bleeding disorders (hemophilia, von Willebran disease, ITP), anemia and white blood cell disorders. He is involved in many clinical trials to advance care for these patients.
Dr. Panigrahi's research focuses on various hematological conditions such as immune thrombocytopenic purpura and also on hematological malignancies such as leukemia. He is also interested in clinical pharmacology and advancement through clinical trials. He is also involved in many aspects of medical education for both medical students and residents.
M.D., University of Massachusetts Medical School, Worcester MA 2007
B.S., University of Illinois, Champaign-Urbana IL 2003
Pediatrics, Tufts- New England Medical Center, Boston MA 2007-2010
Pediatric Hematology-Oncology, University of Chicago Medical Center, Chicago IL 2010-2013
Clinical Pharmacology & Pharmacogenomics, University of Chicago Medical Center, Chicago IL 2011-2013
American Board of Pediatrics, General Pediatrics,
American Board of Pediatrics, Pediatric Hematology-Oncology,
American Society of Hematology (ASH)
American Society of Pediatric Hematology Oncology
Children's Oncology Group
Honors and Awards
NIH�T32�Post�Doctoral�Program�in�Clinical�Pharmacology 2011, 2012, 2013
Select Recent Publications
Sabet K, Dayan Y, Panigrahi AR. Case Series of AML Patients with Acute Heart Failure During Chemotherapy. Pediatr Blood Cancer. 2020.
Robertson R, Cheema R, Panigrahi AR. Rothia Bacteremia, Pneumonia, Meningitis in an Adolescent during AML chemotherapy causing Morbidity. Pediatr Blood Cancer. 2020.
Nessle C, Raj A, Myers JA, Ghosal S, Panigrahi AR. Weak correlation of bleeding scores to platelet electron microscopy: A retrospective chart review of pediatric patients with delta-storage pool disorder. Pediatri Blood Cancer. 2019 March; 66(3):e27505. doi:10.1002/pbc.27505. Epub 2018 Oct 21.
Spiwak E, Wiesenauer C, Panigrahi AR, Raj A. Use of Pleuroperitoneal Shunt in Chylotrorax Related to Central Line Associated Thrombosis in Sickle Cell Disease. Children. 2018 January;5(1):7.
Vlachos A, Atsidaftos A, Muir E, Rogers Z, Lababidi M, Alhushki W, Farrar J, Glader B, Gruner B, Hartung H, Knoll C, Nalepa G, Narla A, Panigrahi AR, Sieff C, Walkovich K, Lipton J. Leucine for the Treatment of Transfusion Dependence in Patients with Diamond Blackfan Anemia. Blood. 2018;132(1):755. doi:10.1182/blood-2018-99-113570.
Mathews C, Nessle C, Panigrahi AR, Ghosal S, Myers J, Taylor D, Raj A, Burnett DH, Massie L. Atypical laboratory findings and varying bleeding scores in patients diagnosed with delta granule platelet storage pool disorder; a retrospective chart review of 80 pediatric patients. J Ameri Hematol. 2018.
Taylor D, Nessle C, Ghosal S, Panigrahi AR. Lack of Correlation between Bleeding Scores and Platelet Electron Microscopy in Delta-Granule Storage Pool Disorder. Pediatr Blood Cancer. 2018.
Panigrahi AR, Clark A, Myers J, Raj A. A Novel Immunomodulatory Treatment Involving Mycophenolate mofetil and Corticosteroids for Pediatric Autoimmune Cytopenias. Pediatri Blood Cancer. 2017 February;64(2):287-293.
Myers S, Eid R, Myers J, Panigrahi AR, Raj A. Long Term Erythrocytapheresis is Associated with Reduced Liver Iron Concentration. J Pediatr Hematol Oncol. 2016 January;38(1):22-6. doi:10.1097/MPH.0000000000000461.
Madian A, Panigrahi AR et al. Inability to Achieve a Therapeutic Dose of Tacrolimus in a Pediatric Stem Cell Transplant Patient due to Generic Substitution. BMC Pharmacol Toxicol. 2014 December 3;15(69). doi:10.1186/2050-6511-15-69.